Physician Photo

Morris F. Ling, MD

  • Phone: 617-726-3850
Allergy and Immunology
Department of Medicine
Clinical Interests
Food allergy
Contact dermatitis
Drug hypersensitivity
Eosinophilic disorders
Boston: Massachusetts General Hospital
Medical Education
MD, University of Maryland School of Medicine
Residency, University of Chicago Hospitals
Fellowship, Massachusetts General Hospital
Board Certifications
Internal Medicine, American Board of Internal Medicine
Allergy & Immunology, American Board of Allergy and Immunology
Patient Gateway
Yes, learn more
Foreign Languages
Patient Age Group
Accepting New Patients


I completed Allergy and Immunology fellowship training at Massachusetts General Hospital after attaining my medical degree at the University of Maryland Medical School and Internal Medicine residency training at the University of Chicago Medical Center.  I am an Instructor at Harvard Medical School and have continued my research training in the lab of Dr. Andrew D. Luster in the Center for Immunology and Inflammatory Diseases at Massachusetts General Hospital.  My research focus is asthma and I have over 4 years of experience in basic and human translational immunology research.

ResearchMy current research is focused on two main areas of interest: 1) the role of chemokines in allergic diseases and 2) allergen-specific T cell immune responses in human asthma. Our lab has identified CCR8 as a human CCL18 receptor, which may have important implications for understanding the pathogenesis of allergic/eosinophilic diseases. I plan to develop novel reporter mouse models to investigate the role of this CCR8 and its chemokine ligands in allergic diseases, including asthma and atopic dermatitis.  I am also investigating and characterizing allergen-specific T cell immune responses, activation/memory markers, cytokine release, and gene expression in human asthma, with a goal toward elucidating the differences between allergic asthmatics and allergic nonasthmatics, which may help reveal the mechanisms that underlie the immunopathogenesis of asthma.

PublicationsIslam S*, Ling MF* (*contributed equally), Leung J, Shreffler WG, Luster AD. Identification of human CCR8 as a CCL18 receptor.  Journal of Experimental Medicine, 2013;210:1889-98.

Wong JT, Ling M, Patil, S, Banerji A, Long A.  Oxaliplatin Hypersensitivity: Evaluation, Implications of Skin Testing, and Desensitization. Journal of Allergy and Clinical Immunology: In Practice (accepted).

Patil, SU, Long AA, Ling M, et al.  A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions.  Journal of Allergy and Clinical Immunology, 2012;129:443-447.

Kim TW, Hung CF, Ling M, Juang J, He L, Hardwick JM, Kumar S, Wu TC.  Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. Journal of Clinical Investigation, 2003;112:109-17.

Hung CF, Cheng WF, He L, Ling M, Juang J, Lin CT, Wu TC.  Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomesN  Cancer Research, 2003;63:2393-8.

Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M, Wu TC.  Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigenN  Journal of Clinical Investigation,  2001;108:669-78.

Wang TL, Ling M, et al.  Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gene Therapy, 2000;7:726-33.

Allergy Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-3850
Fax: 617-724-0239